AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors.
Business Model:
Revenue: $0
Employees: 1-10
Address: 22 Strathmore Rd,
City: Natick
State: MA
Zip: 01760
Country: US
AvengeBio is focusing on Cell-Generated Immunotherapies to eradicate solid tumors. It is a developer of a drug delivery platform intended to treat cancer. The company was founded in 2019 and based in Cambridge, Massachusetts.
Contact Phone:
+12152009192
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Series A | $0 |
CAM Capital Longitude Capital Pappas Capital Perceptive Advisors Rock Springs Capital CAM Capital Longitude Capital Pappas Capital Perceptive Advisors Rock Springs Capital |
3/2020 | Seed Round | 1 | - |
Longitude Capital Longitude Capital |
1/2022 | Series A | 5 | $45M |
Perceptive Xontogeny Venture Fund CAM Capital Longitude Capital Rock Springs Capital Pappas Capital CAM Capital Longitude Capital Pappas Capital Perceptive Advisors Rock Springs Capital |
3/2020 | Seed Round | 1 | - |
Longitude Capital Longitude Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|